In what can be a game-changer, the Oxford COVID-19 vaccine trial results are due this year, and there is a small chance that the vaccine might be out by Christmas, or by early 2021.
Prof Andrew Pollard, chief investigator of the trial, talking to British MPs at a joint hearing of the science and health committees of the House of Commons said, by the year-end, they could reach a point to do an analysis. But then they would need to put their data through to the regulatory authorities, and then policy-related decision will be made.
Pollard said, we are close, but not there yet.
Other vaccines might be approved before the Oxford one, but Pollard said that he hopes that there would be lots of successes because multiple vaccines would be needed for 7 billion people in the world.
If the vaccine works, the world may eventually to go back to normal; however, it does not mean an immediate end to the COVID-19 pandemic.
Also Read: Serum Institute can resume clinical trial of Oxford COVID-19 vaccine candidate in India
